Cash Flow from Investing Activities (Quarterly)

Cash Flow from Investing Activities: The total change in cash resulting from a company's investments.

Fresenius Medical Care AG & Co. KGaA (FMS) had Cash Flow from Investing Activities of $-284.13M for the most recently reported fiscal quarter, ending 2025-06-30.

Quarterly Annual

Figures for fiscal quarter ending 2025-06-30

Income Statement Financials
Revenue	$5.44B
Net Income	$255.73M
Cost of Goods Sold	$4.06B
Gross Profit	$1.38B
Operating Expenses	$4.96B
Operating Income	$482.78M
Non-Operating Income/Expense	$-84.83M
Pre-Tax Income	$397.95M
Normalized Pre-Tax Income	$397.95M
Income after Taxes	$309.11M
Income from Continuous Operations	$309.11M
Consolidated Net Income/Loss	$309.11M
Normalized Income after Taxes	$309.11M
EBIT	$482.78M
EBITDA	$940.97M
Weighted-Average Shares Outstanding (Basic)	586.83M
Weighted-Average Shares Outstanding (Diluted)	586.83M
Earnings per Share (EPS) (Basic)	$0.44
Earnings per Share (EPS) (Diluted)	$0.44
Balance Sheet Financials
Current Assets	$9.24B
Property, Plant, and Equipment	$3.73B
Long-Term Assets	$26.29B
Total Assets	$35.52B
Current Liabilities	$6.43B
Long-Term Debt	$7.18B
Long-Term Liabilities	$12.83B
Total Liabilities	$19.26B
Common Equity	$16.26B
Tangible Shareholders Equity	$-621.28M
Shareholders Equity	$16.26B
Common Shares Outstanding	586.83M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$1.06B
Cash Flow from Investing Activities	$-284.13M
Cash Flow from Financial Activities	$-67.62M
Beginning Cash	$1.35B
End Cash	$1.95B
Increase/Decrease in Cash	$607.12M
Stock-Based Compensation	--
Common Stock Dividends Paid	$-613.30M
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.44
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.31
Debt to Equity Ratio	0.51
Gross Margin	25.34%
Operating Margin	8.88%
EBIT Margin	8.88%
EBITDA Margin	--
Pre-Tax Profit Margin	7.32%
Profit Margin	4.70%
Free Cash Flow	$736.69M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.15
Inventory Turnover	1.79
Receiveable Turnover	1.48
Days Sales in Receivables	60.69
Return on Equity	1.90%
Return on Tangible Equity	-49.75%
Return on Assets	0.87%
Return on Investments	1.32%
Book Value Per Share	$27.71
Free Cash Flow per Share	$1.26
Operating Cash Flow per Share	$1.81

Data from Zacks Investment Research, Inc.